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Abstract
Background
Observational studies have reported that higher plasma 25-hydroxyvitamin D (25[OH]D)
concentrations are associated with lower risks of diabetes, but it is unclear if these associa-
tions are causal. The aim of this study was to test the relevance of 25(OH)D for type 2 diabe-
tes using genetically instrumented differences in plasma 25(OH)D concentrations.
Methods and findings
Data were available on four 25(OH)D single nucleotide polymorphisms (SNPs; n = 82,464),
plasma 25(OH)D concentrations (n = 13,565), and cases with diabetes (n = 5,565) in
the China Kadoorie Biobank (CKB). The effects on risk of diabetes were assessed by a
genetic score using two 25(OH)D synthesis SNPs (DHCR7-rs12785878 and CYP2R1-
rs10741657), with and without the addition of SNPs affecting the transport (GC/DBP-
rs2282679) and catabolism (CYP24A1-rs6013897) of 25(OH)D. The CKB results were com-
bined in a meta-analysis of 10 studies for the 2 synthesis SNPs (n = 58,312 cases) and 7
studies for all 4 SNPs (n = 32,796 cases). Mean (SD) 25(OH)D concentration was 62 (20)
nmol/l in CKB, and the per allele effects of genetic scores on 25(OH)D were 2.87 (SE 0.39)
for the synthesis SNPs and 3.54 (SE 0.32) for all SNPs. A 25-nmol/l higher biochemically
measured 25(OH)D was associated with a 9% (95% CI: 0%–18%) lower risk of diabetes in
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CKB. In a meta-analysis of all studies, a 25-nmol/l higher genetically instrumented 25(OH)D
concentration was associated with a 14% (95% CI: 3%–23%) lower risk of diabetes (p =
0.01) using the 2 synthesis SNPs. An equivalent difference in 25(OH)D using a genetic
score with 4 SNPs was not significantly associated with diabetes (odds ratio 8%, 95% CI:
−1% to 16%, lower risk, p = 0.07), but had some evidence of pleiotropy. A limitation of the
meta-analysis was the access only to study level rather than individual level data.
Conclusions
The concordant risks of diabetes for biochemically measured and genetically instrumented
differences in 25(OH)D using synthesis SNPs provide evidence for a causal effect of higher
25(OH)D for prevention of diabetes.
Author summary
Why was this study done?
• There is a debate about whether low vitamin D status increases the risk of diabetes or is
just a marker of overall poor health. Observational studies have demonstrated that indi-
viduals with higher vitamin D status in European populations have lower risks of devel-
oping type 2 diabetes.
What did the researchers do and find?
• The present report, involving approximately 82,500 adults living in China, replicated
the association of higher vitamin D status with lower risk of type 2 diabetes in Chinese
adults.
• A combined analysis of over 58,000 cases and 370,000 controls in European and Chinese
adults demonstrated that genetically instrumented increases in a circulating marker of
vitamin D status, corresponding to increases achievable by vitamin D supplements,
were associated with a 14% lower risk of diabetes.
What do these findings mean?
• The concordant results of both the observational studies and the genetic studies indicate
that higher vitamin D status is associated with lower risk of diabetes and provide sup-
port for a causally protective effect of higher vitamin D status for prevention of type 2
diabetes.
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Introduction
The incidence of type 2 diabetes has increased substantially in both high-income and low- and
middle-income countries in recent decades [1]. Vitamin D insufficiency, defined as plasma
25-hydroxyvitamin D (25[OH]D) concentration < 75 nmol/l, is common in European and
Asian populations, particularly among those living at high latitude, during the winter months,
or among those in cities with poor air quality [2–4]. Observational studies have reported that
higher plasma 25(OH)D concentrations are associated with lower risks of diabetes [5–7]. A
meta-analysis of 22 prospective studies of individuals of European descent, involving 8,492
cases of diabetes [5], reported that a 25-nmol/l higher 25(OH)D concentration was associated
with a 17% lower risk of diabetes, but the causal relevance of this association is uncertain. Pre-
vious randomised trials have reported conflicting results for the effects of supplementation
with vitamin D on risk of diabetes, but these trials may not have been large enough or used suf-
ficient doses of vitamin D to detect a benefit [8–12].
Mendelian randomisation (MR) studies of genetic variants can help to assess the causal rel-
evance of vitamin D status for risk of diabetes. Since genotypes are randomly assigned before
birth, associations of genetic variants with risk of diabetes are not constrained by confounding
or reverse causality, which limit the interpretation of observational studies [13]. However, the
validity of MR studies is dependent on the effects of the genetic variants on risk of diabetes
being mediated solely via their effects on plasma 25(OH)D concentration and not by some
other trait (pleiotropy) [13]. Genome-wide association studies have identified 4 single nucleo-
tide polymorphisms (SNPs) that influence plasma 25(OH)D concentration (S1 Fig) [14,15].
The genetic variants affecting the synthesis of 25(OH)D, in the genes DHCR7 (encoding
7-dehydrocholesterol reductase enzyme for synthesis of pre-vitamin D3) and CYP2R1 (encod-
ing the 25-hydroxylase enzyme for conversion of vitamin D3 to 25[OH]D), are upstream of 25
(OH)D, and these are not known to have pleiotropic effects (S1 Fig) [13]. In contrast, 2 other
genetic variants, in the genes GC/DBP (the group-specific component that encodes vitamin D
binding protein) and CYP24A1 (which encodes the 24-hydroxylase involved in the clearance
of 25[OH]D), have potential pleiotropic effects (S1 Fig) [13]. The genetic variants involved in
vitamin D binding protein cause discrepant effects on free versus total 25(OH)D concentration
[16,17], and variants affecting the catabolism of vitamin D (CYP24A1) also influence plasma
concentrations of phosphate and FGF-23 [18], such that these genetic variants may affect dia-
betes independent of their effects on 25(OH)D concentration.
Previous MR studies of 25(OH)D and type 2 diabetes have reported conflicting results
[5,19–23], with studies using the 2 synthesis SNPs suggesting a possible protective effect [21],
but studies using all 4 SNPs influencing 25(OH)D concentration reporting no association with
diabetes [5,22]. Since the effects of these SNPs on plasma 25(OH)D concentrations were typi-
cally only about 3–3.5 nmol/l per allele, MR studies require a large number of cases to assess
causality.
The aims of the present study were as follows: (i) to examine the associations of genetic
scores for 25(OH)D concentration with the 2 synthesis SNPs (DHCR7-rs12785878 and
CYP2R1-rs10741657) versus all available SNPs (2 synthesis SNPs in addition to 1 transport
SNP [GC/DBP-rs2282679] and 1 catabolism SNP [CYP24A1-rs6013897]) in 82,464 Chinese
adults from the China Kadoorie Biobank (CKB) [24]; (ii) to conduct an updated meta-analysis
of all genetic studies assessing the effects of genetically instrumented differences in plasma 25
(OH)D concentrations on risk of type 2 diabetes in a primary analysis using the 2 synthesis
SNPs and a secondary analysis using all 4 SNPs for 25(OH)D concentration; and (iii) to com-
pare the risks of diabetes associated with equivalent differences in biochemically measured ver-
sus genetically instrumented plasma 25(OH)D concentrations.
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Methods
CKB study population
Details of the CKB study design, methods, and participants have been previously reported [24]
(S1 Table). The 512,891 participants were enrolled from 10 geographically diverse urban and
rural areas in China. Participants aged 30–79 years were identified through local residential
records and invited to attend survey clinics (~30% responded) [24]. The baseline survey was
conducted between June 2004 and July 2008 and included data on demographic and lifestyle
factors, medical history, and use of medication (see http://www.ckbiobank.org for details of
questionnaire used in baseline survey). Physical measurements included blood pressure,
weight, height, body mass index (BMI), waist—hip ratio (WHR), and body fat percentage. A
10-ml non-fasting venous blood sample was collected (with time of last meal recorded), and
random plasma glucose was measured on site (Johnson & Johnson SureStep Plus, LifeScan).
Ethics approval was obtained from the relevant local, national, and international ethics com-
mittees, and all participants provided written informed consent.
Assays of plasma 25(OH)D concentration in CKB
After centrifugation of thawed stored EDTA plasma samples, plasma 25(OH)D concentration
was measured using a Beckman Coulter Access 2 immunoassay in 13,565 participants (of
whom 3,014 also participated in the genetic study). The laboratory participated in an interna-
tional DEQAS scheme for 25(OH)D and had a mean (SD) bias of −11.8% (7.5%) from the tar-
get mean value during the analysis of the CKB study.
Observational association of 25(OH)D concentration with diabetes in CKB
Participants answering “yes” to the question, “Has a doctor ever told you that you had diabe-
tes?” at baseline were defined as having prevalent diabetes. Incident cases of diabetes were
identified by electronic linkage to disease registries and national health insurance databases for
hospitalisations due to diabetes (using International Classification of Diseases classification
codes E10–E14 or use of specific antidiabetic medication). The present analysis included all
incident cases occurring after baseline and prior to 1 January 2014. (Detailed review of medical
records of 1,000 randomly selected incident cases of diabetes indicated a positive predictive
value of 97% based on American Diabetes Association diagnostic criteria; see http://www.
ckbiobank.org). After excluding the 496 individuals with prevalent diabetes at baseline (to
avoid reverse causality), the observational association of plasma 25(OH)D concentration with
incident type 2 diabetes was assessed with 979 cases among 13,069 individuals with plasma 25
(OH)D concentration in CKB.
SNP selection and genotyping in CKB
A total of 95,680 randomly selected CKB participants were genotyped using a panel of 384
SNPs (Illumina GoldenGate) (S2 Table). The genotyping panel included 2 synthesis SNPs
(DHCR7-rs12785878 and CYP2R1-rs10741657), 1 transport SNP (GC/DBP-rs2282679), and 1
catabolism SNP (CYP24A1-rs6013897), identified as significantly associated with plasma 25
(OH)D concentration in previous genome-wide studies [14]. The genotyping concordance
was>99.9% for 2,063 pairs of sample replicates, and the genotyping success rate was 99.9%
for each SNP. Samples with genotype call rate< 98%, excessive heterozygosity, gender mis-
match between reported and genetically inferred gender, missing genotype data for relevant
SNPs, or other potential linkage errors were excluded, as were first-degree relatives of included
Association of vitamin D with type 2 diabetes in European and Chinese adults
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participants, leaving 82,464 individuals for genetic analysis. All genetic analyses in CKB
included both prevalent and incident cases of diabetes.
Meta-analysis of all genetic studies
Using the search terms “genetic studies of plasma 25(OH)D concentrations” or “genetic stud-
ies of vitamin D” or “diabetes”, we sought to identify further genetic studies, in addition to
those included in a previous meta-analysis in 2015, for 25(OH)D and risk of diabetes using the
PubMed and Web of Science databases [5]. Studies were restricted to those involving relevant
genetic variants for 25(OH)D and at least 500 cases with diabetes. Five published reports
[5,19–22] were identified (the EPIC-Germany [19], Tromsø [20], Copenhagen [21], and
EPIC-Norfolk [22] studies and a meta-analysis of multiple European studies [5] [CCCS,
ADDITION-Ely, Norfolk Diabetes, EPIC-InterAct, and DIAGRAM]; S2 and S3 Figs; S2
Table). The EPIC-Germany study [19] and the EPIC-Norfolk study [22] were excluded as they
had been previously included in EPIC-InterAct. The Tromsø study was excluded because of
missing data on the genotype distributions [20]. Additional unpublished data were obtained
from the CKB study, the UK Biobank resource, the Copenhagen study [21], and non-overlap-
ping individuals in the T2D Exome consortium (a meta-analysis of 40,723 non-overlapping
individuals among 79,854 T2D case—control samples genotyped using the exome array for
the DIAGRAM and T2D-GENES Consortium; S3 Table; S3 Fig). All 10 studies (UK Biobank,
Norfolk Diabetes, DIAGRAM, Copenhagen, CCCS, ADDITION-Ely, T2D Exome consor-
tium, EPIC-InterAct-metabochip, EPIC-InterAct-gwas, and CKB) included data on both syn-
thesis SNPs and the transport SNP (GC/DBP), whereas only 7 of the studies had the catabolism
SNP (CYP24A1).
Statistical methods
Pre-specified analysis plan. It was pre-specified to first conduct an observational analysis
of the association of plasma 25(OH)D with risk of diabetes in CKB, and assess associations of
genetic variants with 25(OH)D and with diabetes in CKB, and then subsequently conduct an
updated meta-analysis of the worldwide studies of genetic variants and risk of diabetes. The
primary analyses were pre-specified to investigate the effects of the synthesis SNPs on risk of
diabetes, and the secondary analyses assessed the effects of all four 25(OH)D SNPs on risk of
diabetes. Pleiotropy was investigated for all 4 SNPs available in 7 studies and the 3 SNPs avail-
able in all 10 studies. Lastly, the analyses then compared the risks of diabetes associated with
equivalent differences in biochemically measured and genetically instrumented 25(OH)D con-
centrations in the worldwide studies.
Observational analysis in CKB. Logistic regression analysis was used to estimate log
odds ratios (ORs) and 95% confidence intervals (CIs) of incident diabetes for tertiles (or per
25-nmol/l higher 25[OH]D) after adjustment for age, sex, latitude, systolic blood pressure
(SBP), physical activity, and percent body fat. The 95% CI for the OR for each tertile was plot-
ted using floating absolute risks by estimation of the variance of the log risk, so that each tertile
of 25(OH)D was accompanied by a 95% CI derived from the variance of the log risk for that
tertile [25].
Genetic analyses in CKB. Genotype distributions of each SNP and deviation from
Hardy—Weinberg equilibrium were assessed separately in each of the 10 geographical areas.
Linear regression was used to assess the per allele effect of each SNP on plasma 25(OH)D con-
centration in the subset of 3,014 individuals with plasma 25(OH)D concentrations using
10-fold cross-validation to estimate valid internal weights [26]. Genetic scores were estimated
for the 2 synthesis SNPs and all four 25(OH)D SNPs. The per allele effects on plasma 25(OH)
Association of vitamin D with type 2 diabetes in European and Chinese adults
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D concentrations of the specified combinations of SNPs were used to construct the respective
weighted genetic scores for 25(OH)D. The F-statistic was used to estimate the strength of the
association of each SNP with 25(OH)D concentration, and F-statistic values> 10 were consid-
ered strong [26].
Linear regression was also used to assess the associations of each SNP with SBP, diastolic
blood pressure (DBP), BMI, WHR, percent body fat, and random plasma glucose. All the
genetic analyses were conducted separately for each area after adjusting for age at baseline, sex,
and season, and were subsequently combined using inverse-variance-weighted meta-analysis.
Logistic regression was used to assess associations of individual SNPs and genetic scores
with diabetes, separately for each area, and subsequently analyses were combined using
inverse-variance-weighted meta-analysis. The per allele effect of each SNP on plasma 25(OH)
D concentration in CKB was expressed as the difference in 25(OH)D concentration per copy
of the 25(OH)D-raising allele. Instrumental variable analysis was used to estimate the causal
effects of differences in genetically instrumented higher plasma 25(OH)D concentrations on
risk of diabetes as previously described [26].
Updated meta-analysis of all genetic studies. The log ORs for diabetes per 25(OH)D-
increasing allele and their standard errors for all SNPs were extracted from all the identified
studies for the meta-analysis as previously described [26]. The log ORs for the SNPs and for
the genetic scores combining the SNPs for risk of diabetes were scaled to 25-nmol/l higher 25
(OH)D concentrations in all studies [26]. The effects of individual SNPs and the genetic scores
on risk of diabetes in individual studies were combined in a meta-analysis by inverse-variance
weighting using a fixed-effects model. Additional sensitivity analyses included combinations
of (i) the lead synthesis and transport SNPs with the maximum effect on 25(OH)D concentra-
tion and (ii) both synthesis SNPs and the lead catabolism SNP. The per allele effects in all stud-
ies were weighted by the effect of each SNP on 25(OH)D concentration. Additional sensitivity
analyses were conducted for the 3-SNP and 4-SNP genetic scores to assess the effects of pleiot-
ropy using the MR—Egger regression method (where the p-value of the intercept is a valid test
of directional pleiotropy) and the weighted median MR method [27]. All the statistical analyses
were conducted using SAS version 9.2 and R version 3.01, and all reported p-values were nom-
inal and 2-sided.
Results
Characteristics of the CKB population
Among the 82,464 CKB participants in the genetic study, the mean (SD) age was 51.4 (10.6)
years, 61% were women, and the mean (SD) BMI was 23.7 (3.4) kg/m2. The baseline character-
istics of the genotyped participants were similar to those of the subset with plasma 25(OH)D
concentrations except for prior history of cardiovascular disease, which was an exclusion crite-
rion in the biochemistry study (Table 1). The overall mean plasma 25(OH)D concentration
was 62.1 (20.2) nmol/l, consistent with values previously reported in Chinese and in European
populations. Mean plasma concentration of 25(OH)D was lower in participants recruited in
winter than in summer (57.4 versus 68.4 nmol/l, respectively), but was unrelated to age, sex,
physical activity, or percent body fat (S3 Table).
Association of biochemically measured 25(OH)D concentration with
diabetes in CKB
In CKB, biochemically measured plasma 25(OH)D concentration was inversely associated
with risk of incident diabetes after adjustment for age, sex, season, area, and additional
Association of vitamin D with type 2 diabetes in European and Chinese adults
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confounding factors (S4 Fig). The association of 25(OH)D with diabetes was largely unaltered
after sequential adjustment for the possible confounders: latitude, sex, SBP, physical activity,
age, and percent body fat (S5 Fig). After adjustment for potential confounding factors, a
25-nmol/l higher 25(OH)D concentration was associated with a 9% (95% CI: 0%–18%) lower
risk of incident diabetes in CKB, consistent with the 17% (95% CI: 13%–21%) lower risk previ-
ously reported in European populations (S4 Table). Combined analysis of both Chinese and
European populations suggested that a 25-nmol/l higher biochemically measured plasma 25
(OH)D concentration was associated with a 16% (95% CI: 12%–19%) lower risk of diabetes
(S4 Table).
Effect of latitude on 25(OH)D concentration
In CKB, mean plasma 25(OH)D concentration was inversely related to latitude, with about a
2-fold greater mean plasma 25(OH)D concentration in the extreme south area (Haikou)
Table 1. Selected characteristics for all participants with 25-hydroxyvitamin D (25[OH]D) measured and genetic
data in the China Kadoorie Biobank (CKB).
Baseline characteristic CKB participants with 25(OH)D measured1
(n = 13,565)
CKB participants with genetic data2
(n = 82,464)
Demographic
Age, years 53.2 (11.2) 51.4 (10.6)
Women 49.2% 60.5%
Current smoker 47.2% 36.9%
Current drinker 56.8% 53.7%
Body mass index, kg/m2 23.6 (3.5) 23.7 (3.4)
Random blood glucose,
mmol/l
6.2 (2.8) 6.1 (2.4)
Systolic blood pressure,
mm Hg
140.2 (25.9) 131.2 (21.3)
Diastolic blood pressure,
mm Hg
82.2 (14.5) 77.8 (11.2)
Doctor-diagnosed prior
disease
Heart disease 0.0% 3.0%
Stroke/transient ischemic
attack
0.0% 1.8%
Hypertension 15.9% 11.5%
Diabetes 3.7% 3.2%
Cancer 0.0% 0.5%
Current medication use
Statin 0.0% 0.2%
Aspirin 1.3% 1.1%
Blood-pressure-lowering
drug
6.1% 4.8%
Plasma 25(OH)D, nmol/l 62.0 (20.3) 62.1 (20.2)
Data are given as mean (SD) or percent.
1Included in observational analysis of 25(OH)D concentration and diabetes.
2Included in Mendelian randomisation (MR) analyses of genetically instrumented 25(OH)D concentration and
diabetes; 3,014 individuals with both 25(OH)D measurement and genetic data were included in genetic analyses of 25
(OH)D concentrations and MR analyses.
https://doi.org/10.1371/journal.pmed.1002566.t001
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compared with the extreme north area (Harbin) of China (90 nmol/l at 20˚ versus 49 nmol/l at
46˚; S5 Table).
Effect of genetic variants on 25(OH)D in CKB
DHCR7-rs12785878, CYP2R1-rs10741657, and GC/DBP-rs2282679 were significantly associ-
ated with plasma 25(OH)D concentration (Table 2). Although CYP24A1-rs6013897 was not
significantly associated with 25(OH)D concentration, the direction of effect was consistent
with previous studies [14]. The mean (SE) per allele effect on 25(OH)D concentration of the
genetic score for the 2 synthesis SNPs was 2.87 (0.39) nmol/l (F-statistic = 21.9), and for the
genetic score for all 4 SNPs was 3.54 (0.32) nmol/l (F-statistic = 93.1), in CKB. The estimates
were consistent with the previously reported per allele effects on 25(OH)D concentration of
these genetic scores in Europeans: 2.72 (0.41) and 3.10 (0.29) nmol/l, respectively [5]. The 25
(OH)D-increasing allele frequencies were 0.46 for DHCR7-rs12785878, 0.36 for CYP2R1-
rs10741657, 0.84 for CYP24A1-rs6013897, and 0.70 for GC/DBP-rs2282679, respectively, in
CKB overall, and showed associations towards being higher in those living in northern than in
southern latitudes in China (S5 Table). In contrast, the corresponding frequencies for both
transport and metabolism SNPs varied little by latitude. There were weak associations towards
higher mean effects for the 2-SNP score on 25(OH)D concentrations with more northerly lati-
tude, where the overall concentration of 25(OH)D was higher (although there is likely to be
some misclassification of latitude in such large-scale genetic studies).
None of the 4 SNPs was associated with differences in blood pressure, BMI, WHR, percent
body fat, or random plasma glucose concentration in CKB (Table 2).
Genetic variants and risk of diabetes in CKB
In CKB, none of the individual variants were significantly associated with risk of diabetes
(n = 5,566), with per allele adjusted ORs (95% CIs) of 0.97 (0.93–1.01) for DHCR7-rs12785878,
Table 2. Association of 25(OH)D SNPs with plasma 25(OH)D concentrations and with cardiometabolic risk factors.
SNP 25(OH)D, nmol/l SBP, mm Hg DBP, mm Hg BMI, kg/m2 Waist—hip ratio Body fat percent Random blood glucose, mmol/l
rs12785878 (DHCR7)
Per T allele 2.84 (0.41) 0.10 (0.10) 0.05 (0.05) −0.01 (0.02) −0.00 (0.08) −0.00 (0.03) 0.00 (0.01)
p-Value for trend 2.3 × 10−12 0.31 0.32 0.70 0.98 0.99 0.94
rs10741657 (CYP2R1)
Per A allele 0.95 (0.42) −0.02 (0.10) 0.01 (0.06) 0.02 (0.02) −0.10 (0.08) 0.07 (0.03) −0.01 (0.01)
p-Value for trend 0.03 0.83 0.88 0.21 0.21 0.02 0.38
rs6013897 (CYP24A1)
Per A allele 0.51 (0.56) 0.14 (0.13) 0.09 (0.07) 0.00 (0.02) 0.03 (0.11) −0.01 (0.04) 0.01 (0.01)
p-Value for trend 0.37 0.28 0.23 0.89 0.76 0.73 0.37
rs2282679 (GC/DBP)
Per T allele 3.59 (0.44) −0.06 (0.10) −0.06 (0.06) 0.01 (0.02) 0.11 (0.09) 0.00 (0.03) 0.02 (0.01)
p-Value for trend 2.2 × 10−16 0.58 0.28 0.39 0.20 0.99 0.09
Data are given as mean (SE) and p-value. For SNP rs12785878: n = 3,004 for 25(OH)D, n = 82,448 for SBP, DBP, BMI, and waist—hip ratio, n = 82,393 for body fat
percent, and n = 81,637 for random blood glucose. For SNP rs10741657: n = 3,011 for 25(OH)D, n = 82,452 for SBP, DBP, BMI, and waist—hip ratio, n = 82,397 for
body fat percent, and n = 81,641 for random blood glucose. For SNP rs6013897: n = 3,014 for 25(OH)D, n = 82,396 for SBP, DBP, BMI, and waist—hip ratio, n = 82,341
for body fat percent, and n = 81,585 for random blood glucose. For SNP rs2282679: n = 3,013 for 25(OH)D, n = 82,296 for SBP, DBP, BMI, and waist—hip ratio,
n = 82,242 for body fat percent, and n = 81,485 for random blood glucose. All values are adjusted for age, sex, and season, and stratified by area.
25(OH)D, 25-hydroxyvitamin D; DBP, diastolic blood pressure; SBP, systolic blood pressure.
https://doi.org/10.1371/journal.pmed.1002566.t002
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1.00 (0.96–1.04) for CYP2R1-rs10741657, 1.00 (0.95–1.05) for CYP24A1-rs6013897, and 1.01
(0.96–1.05) for GC/DBP-rs2282679 (S6 Fig). The per allele adjusted OR (95% CI) of the genetic
score for the 2 synthesis SNPs was 0.97 (0.93–1.01) and for the genetic score for all 4 SNPs was
0.99 (0.96–1.02).
Genetic variants and risk of diabetes in an updated meta-analysis of all
studies
In the updated meta-analysis of all 10 studies, the primary analysis involved a total of 58,312
cases and 370,592 controls (S2 Fig), and a 25-nmol/l higher genetically instrumented plasma
25(OH)D concentration using the 2 synthesis SNPs was associated with a 14% (95% CI: 3%–
23%) lower risk of diabetes (p = 0.01; Fig 1). The secondary analyses, involving a meta-analysis
Fig 1. Association of genetic score using synthesis SNPs for 25(OH)D concentration with risk of diabetes in a meta-analysis of
all studies per 25-nmol/l higher genetically instrumented 25(OH)D concentration. Values shown are the odds ratios (95% CIs)
per 25-nmol/l higher 25(OH)D concentration among studies stratified by latitude into northern (>50˚) or southern latitude
(50˚). The area of the squares is proportional to the inverse variance of each effect size. The effects of all SNPs on risk of diabetes
in Chinese and European populations were weighted by their effects on 25(OH)D concentration. 25(OH)D, 25-hydroxyvitamin D;
CCCS, Cambridgeshire case—control study; CKB, China Kadoorie Biobank; DIAGRAM, Diabetes Genetics Replication and Meta-
analysis; UKB, UK Biobank.
https://doi.org/10.1371/journal.pmed.1002566.g001
Association of vitamin D with type 2 diabetes in European and Chinese adults
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002566 May 2, 2018 9 / 17
of 7 of the 10 studies, including 32,796 cases and 248,629 controls with complete data on all
synthesis, transport, and catabolism SNPs, indicated that an equivalent difference in 25(OH)D
was associated with only an 8% (95% CI: −1% to 16%) lower risk of diabetes (p = 0.07) (Fig 2).
Analyses based on the 3 SNPs available in all 10 studies gave a similar result (S7 Fig). The esti-
mates for the 2- versus 4-SNP genetic scores in the original and updated meta-analyses were
concordant with each other and with the results from the observational studies for an equiva-
lent difference in plasma 25(OH)D concentration in both Chinese and in European popula-
tions (Fig 3).
Sensitivity analyses
S8 Fig shows some evidence of pleiotropy for the transport and catabolism SNPs in Chinese
and European populations, and the p-values for the MR—Egger intercept (a test of directional
Fig 2. Association of genetic score using all 4 SNPs for 25(OH)D concentration with risk of diabetes in a meta-analysis of all
studies per 25-nmol/l higher genetically instrumented 25(OH)D concentration. Values shown are the odds ratios (95% CIs) per
25-nmol/l higher 25(OH)D concentration among studies stratified by latitude into northern (>50˚) or southern latitude (50˚).
Symbols and conventions as in Fig 1. The effects of all SNPs on risk of diabetes in Chinese and European populations were
weighted by their effects on 25(OH)D concentration. 25(OH)D, 25-hydroxyvitamin D; CCCS, Cambridgeshire case—control study;
CKB, China Kadoorie Biobank; DIAGRAM, Diabetes Genetics Replication and Meta-analysis; UKB, UK Biobank.
https://doi.org/10.1371/journal.pmed.1002566.g002
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pleiotropy) were 0.064 and 0.045 for the 4-SNP and 3-SNP genetic scores, respectively, sug-
gesting possible pleiotropy for the transport and catabolism SNPs.
Discussion
This MR study of genetic variants influencing the synthesis of plasma 25(OH)D concentration,
involving over 58,000 cases and 370,000 controls, demonstrated concordant risks of diabetes
for genetically instrumented differences in 25(OH)D using synthesis SNPs and biochemically
measured differences, and provides novel evidence for a causal protective effect of higher 25
(OH)D concentrations on risk of diabetes. The present meta-analysis included substantially
more cases than a previously reported meta-analysis (involving only 28,144 cases and 76,344
controls) [5] and reported that a 25-nmol/l higher genetically instrumented plasma 25(OH)D
concentration using the synthesis SNPs was associated with a 14% (95% CI: 3%–23%) lower
risk of diabetes. The concordance of genetic studies of 25(OH)D-raising alleles using the syn-
thesis SNPs and risk of diabetes in both Chinese and European populations indicates a protec-
tive effect of higher plasma 25(OH)D concentrations for risk of diabetes.
The results of the present study indicate that a genetically instrumented 25-nmol/l higher
plasma 25(OH)D concentration using all 4 SNPs was associated with only an 8% (95% CI:
−1% to 16%) lower risk of diabetes (based on half the number of cases). However, several stud-
ies have reported that both the transport and catabolism SNPs show biological evidence of
pleiotropy [13,16,17]. Analysis of the associations of the transport and catabolism SNPs with
Fig 3. Comparison of the associations of biochemically measured and genetically instrumented 25-nmol/l higher plasma 25
(OH)D concentrations with risk of diabetes. The full details of the adjustments in the observational analyses are provided in S3
Table. Other symbols and conventions as in Fig 1. 25(OH)D, 25-hydroxyvitamin D; CKB, China Kadoorie Biobank.
https://doi.org/10.1371/journal.pmed.1002566.g003
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diabetes also shows modest statistical evidence of pleiotropy (S8 Fig). Previous studies have
suggested biological evidence of pleiotropy for GC/DBP-rs2282679, which influences vitamin
D binding protein, resulting in discrepant ratios of free to total plasma 25(OH)D concentra-
tions and alteration in feedback control of 25(OH)D concentrations [13,16,17]. In addition,
vitamin D binding protein also carries actin (a chemotactic factor implicated in inflamma-
tion), which may affect diabetes independent of the effect on 25(OH)D concentrations [28,29].
Individuals living near the equator, and who are also routinely exposed to sunlight, have
substantially higher plasma 25(OH)D concentrations than those living in northern latitudes
(with those living above about 35˚ having little or no vitamin D production from skin during
the winter months) [2]. In addition to showing an almost 2-fold difference in mean plasma 25
(OH)D concentration (90 nmol/l at 20˚ versus 49 nmol/l at 46˚), the present analysis of 25
(OH)D concentrations in CKB demonstrated that latitude influenced the 25(OH)D-increasing
allele frequencies, indicating a possible selection effect. However, the present study had limited
power to detect an effect of latitude on the association of the 2-SNP genetic score for 25(OH)D
with risk of diabetes either in CKB or in the meta-analysis of all studies. It is possible that inci-
dence of type 2 diabetes may have been underestimated in this MR study in the absence of
population-wide screening programmes for diabetes in the populations studied.
While a previous study reported modest associations of a 2-SNP genetic score with blood
pressure and risk of hypertension [30], the present study demonstrated no effect of the individ-
ual variants on blood pressure, blood glucose, or any measure of adiposity in the Chinese
population. None of these variants were associated with fasting blood glucose or insulin con-
centrations in previously published studies in Western populations [23], but many variants
affecting risk of diabetes have no detectable effect on fasting glucose or insulin concentrations
in Western populations, so this should not be regarded as an indication of inconsistency [22].
Meta-analyses of genetic studies conducted in different populations cannot exclude the possi-
bility of uncorrected population stratification in individual studies. However, the analyses of
the individual variants and both the 2-SNP and 4-SNP genetic scores in CKB were conducted
within areas, and area-specific estimates were combined using inverse-variance weighting,
which should minimise effects of population stratification for the CKB analyses.
The association between vitamin D and diabetes is biologically plausible [31,32]. In vitro
studies showed that treatment with 1,25(OH)2D, the bioactive form of vitamin D, can stimu-
late insulin gene expression and regulate calcium flux in β cells in human pancreatic cell lines,
which is important for insulin production and secretion [32,33]. Likewise, vitamin D—defi-
cient rats had improved insulin status after injection with 1,25-dihydroxyvitamin D3 [33].
Hence, improving vitamin D status might be a potential method to improve β cell function
and subsequently decrease the risk of diabetes.
The findings of the present study have potentially important implications for public health
policies on food fortification with vitamin D for prevention of diabetes (in addition to effects
on bone health and other disease outcomes). Population-wide supplementation with vitamin
D could afford a simple and cost-effective approach for prevention of diabetes in vitamin D—
deficient populations. Indeed, some studies have already suggested that the introduction of
vitamin D fortification in Finland, a population with limited exposure to sunlight, attenuated
secular trends of increasing incidence of type 1 diabetes [34].
Previous randomised trials of vitamin D supplementation were not designed to assess the
effects on risk of incident diabetes [8–12]. However, some large trials have tested effects of rela-
tively low doses of vitamin D on diabetes or on glycaemic traits [8–12]. However, the doses of
vitamin D used in several of these trials, typically raised 25(OH)D by only 10–20 nmol/l and,
hence, may not have been sufficient to produce any detectable effects on the incidence of dia-
betes or on glycaemic traits [35]. Moreover, the duration of these trials may not have been
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long enough to detect effects on diabetes compared to the lifelong differences in 25(OH)D
concentrations in MR studies. The results of ongoing or planned large-scale trials testing the
effects of higher doses of vitamin D (involving at least 2,000 IU daily) are needed to address
the effect of vitamin D on incidence of diabetes. The D2d trial in the US is currently assessing
whether supplementation with 4,000 IU vitamin D or placebo delays the onset of type 2 diabe-
tes in 2,382 individuals with pre-diabetes [36]. Ongoing trials of vitamin D supplementation
may not be able to accrue sufficient numbers of type 2 diabetes cases for reliable assessment of
the effect of vitamin D on the risk of type 2 diabetes, and additional trials with larger numbers
of such cases may be needed. The results of meta-analysis of ongoing and future trials of vita-
min D supplementation are required before advocating use of vitamin D supplements (or food
fortification) for the prevention of diabetes.
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